Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:09 AM
Ignite Modification Date:
2025-12-25 @ 3:09 AM
NCT ID:
NCT02980705
Eligibility Criteria:
Inclusion Criteria:
* Subject has provided informed written consent
* Subject is ≥ 18 years of age at time of Screening
* Subject must be on a stable dose of NSAID for ≥ 2 weeks prior to initiation of investigational product
* Subject has a negative test for TB within 4 weeks before initiating IMP
Exclusion Criteria:
* Subjects with known diagnosis of fibromyalgia or complex regional pain syndromes
* Active uveitis or symptomatic inflammatory bowel disease requiring therapy at screening
* Radiographic evidence of total ankylosis of the spine
* Subject has a planned surgical intervention between Baseline and the Week 24 evaluation for a pre-treatment condition
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02980705
Study Brief:
Protocol Section:
NCT02980705